KFS
VXRT

Kelly Financial Services’s Vaxart VXRT Stock Holding History

Kelly Financial Services’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,000
Closed -$6.65K – 618
2020
Q3 		$6.65K Buy
+1,000
New +$8.91K ﹤0.01% 295

Other funds holding VXRT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Kelly Financial Services's VXRT Position: Q4 2020 in Review

Kelly Financial Services sold out of Vaxart (VXRT) in Q4 2020, closing a stake of 1,000 shares — an estimated $6.65K sold.

Kelly Financial Services first reported a position in VXRT in Q3 2020 and held it in 1 quarter. The position peaked at $6.65K in Q3 2020. 141 funds tracked by Wall St. Rank hold VXRT as of Q4 2020.

  • Kelly Financial Services reported no remaining Vaxart position as of Q4 2020 after selling out during the quarter.
  • Kelly Financial Services sold 1,000 Vaxart shares in Q4 2020, an estimated $6.65K.
  • Kelly Financial Services first reported a position in Vaxart in Q3 2020 and held it in 1 quarter.
  • Kelly Financial Services's Vaxart position peaked at $6.65K in Q3 2020.
  • 141 funds tracked by Wall St. Rank held Vaxart as of Q4 2020.

Based on Kelly Financial Services's 13F filing for Q4 2020, filed 17 Jul 2024.